World’s first successful caesarean delivery performed at the lowest documented maternal platelet count (1,000/μl) with sustained maternal and neonatal outcomes

Neethi Mala Mekala

doi:10.18203/2320-1770.ijrcog20254317

Authors

Neethi Mala Mekala High Risk Pregnancy Expert, Medicover Hospitals, Chandanagar, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20254317

Keywords:

Severe thrombocytopenia, Lowest platelet count, Successful cesarean section, Fetal distress, High risk pregnancy, Severe immune thrombocytopenia, ITP

Abstract

Severe thrombocytopenia in pregnancy poses a major challenge for obstetric management, particularly when platelet counts fall below critical thresholds. Cesarean delivery under such conditions carries an exceptionally high risk of hemorrhage and maternal morbidity. Reports of successful maternal and neonatal outcomes at platelet counts around 1000/µL are not available in literature. We present this high-risk pregnancy case of a woman with rare O negative blood group, decreased fetal movements, severe oligohydramnios, fetal distress and an extremely low platelet count (1000/µL)-severe immune thrombocytopenia at 35 week 2 days gestational age (GA). Despite the unprecedented hematological risk, fetal distress mandated urgent intervention. The surgery was successful, resulting in the survival of both mother and neonate. Follow‑up over three years confirmed sustained maternal and neonatal health. This case represents a unique milestone in obstetric surgery worldwide-the first documented successful cesarean section performed during pregnancy at the lowest reported platelet count (1,000/µL) at the time of delivery, with long‑term survival of both mother and child. It highlights the importance of individualised management, timely intervention, meticulous preparation, and sound clinical judgment in achieving favourable outcomes despite extraordinary hematological risk.

Metrics

Metrics Loading ...

References

ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstet Gynecol. 2019;133(3):e181-93. DOI: https://doi.org/10.1097/AOG.0000000000003100

Wang X, Xu Y, Luo W. Thrombocytopenia in pregnancy with different diagnoses: Differential clinical features, treatments, and outcomes. Medicine. 2017;96(29):e7561. DOI: https://doi.org/10.1097/MD.0000000000007561

Fogerty AE, Kuter DJ. How I treat thrombocytopenia in pregnancy. Blood. 2024;143(9):747 56. DOI: https://doi.org/10.1182/blood.2023020726

Beltrami-Moreira M, Sharma A, Bussel JB. Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management. Expert Rev Hematol. 2024;17(9):595-607. DOI: https://doi.org/10.1080/17474086.2024.2385481

British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574-96. DOI: https://doi.org/10.1046/j.1365-2141.2003.04131.x

Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. Indian J Hematol Blood Transfus. 2012;28(2):77-81. DOI: https://doi.org/10.1007/s12288-011-0107-x

Cines DB, Levine LD. Thrombocytopenia in Pregnancy. Blood. 2017;130:2271-7. DOI: https://doi.org/10.1182/blood-2017-05-781971

Stavrou E, McCrae KR. Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am. 2009;23(6):1299-316. DOI: https://doi.org/10.1016/j.hoc.2009.08.005

Poston JN, Gernsheimer TB. Management of immune thrombocytopenia in pregnancy. Ann Blood 2021;6:5. DOI: https://doi.org/10.21037/aob-20-58

Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 2002;75(4):426-33. DOI: https://doi.org/10.1007/BF02982137

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-817. DOI: https://doi.org/10.1182/bloodadvances.2019000812

Sayed G, ElKourashy SA, Alnajjar M, Mallahi NA and Fareed S. Case Report: Thrombopoietin receptor agonists in resistant thrombocytopenia in pregnancy: a case series and review of literature. Front Hematol. 2023;2:1180156. DOI: https://doi.org/10.3389/frhem.2023.1180156

Pal S, Kansaria HJ. Case Series: Maternal and Fetal Outcome in Patients with Immune Thrombocytopenic Purpura Admitted to a Tertiary Care Institution. J South Asian Feder Obst Gynae. 2024;16(3):S259-62. DOI: https://doi.org/10.5005/jp-journals-10006-2441

Kashyap R, Garg A, Pradhan M. Maternal and Fetal Outcomes of Pregnancy in Patients with Immune Thrombocytopenia. J Obstet Gynaecol India. 2021;71(2):124-30. DOI: https://doi.org/10.1007/s13224-020-01390-w

Ersan F, Alpay V, Boza B, Erenel H. Severe Thrombocytopenia in Pregnancy: Etiology, Management, and Outcomes Across Platelet Count Categories. J Clin Med. 2025;14:8162. DOI: https://doi.org/10.3390/jcm14228162

Vera-Aguilera C, Torres-Zazueta JM, Konkler J, VeraAguilera J, Soto-Hopkins SA. General Anesthesia for Cesarean Section in a Pregnant Woman with Immune Thrombocytopenic Purpura (ITP): A Case Report and Review of the Literature. Open J Anesthesiol. 2022;12:49-54. DOI: https://doi.org/10.4236/ojanes.2022.121005

The Times of India. Telangana: Pregnant patient at high risk saved. Available at: https://timesofindia. indiatimes.com/city/hyderabad/pregnant-patient-at-high-risk-saved/articleshow/90886557.cms. Accessed on 17 April 2025.

Deccan Chronicle. Nation/ DC correspondent: Doctors save rare high-risk pregnant woman, child. Available at: https://www.deccanchronicle.com/ nation/in-other-news/160422/doctors-save-rare-high-risk-pregnant-woman-child.html. Accessed on 17 April 2025.